A navigation link can point toward a service without documenting what that service actually provides. That distinction is central to Everglow Miami: its website lists weight management and includes a link labeled “GLP-1,” but the consulted sources do not confirm a GLP-1 program. The documented business is a local aesthetic and wellness medical spa. For someone investigating prescription weight care, the first question is therefore not how its treatment compares with clinical trials, but what treatment, if any, the practice is offering.
This review examines public documentation consulted October 19, 2026, separating concrete business details from promotional language and unresolved clinical questions. Everglow provides useful information about its advertised team, Miami location, booking process, cancellation charges and privacy practices. It provides substantially less information in the consulted material about weight-management care itself. That imbalance supports a related-care classification, not verification as a GLP-1 medication provider. It also leaves several practical questions worth resolving before paying for services or submitting detailed health information.
At a glance
- GLP-1 status
- The consulted sources do not confirm a GLP-1 program. Weight management appears among services, and navigation includes a “GLP-1” link, but no specific medication offering is documented.
- Documented location
- Everglow lists 9400 NW 12th Ave, Bay 3, Miami, FL 33150, and directs booking calls to (305) 200-3734.Sources: [8]
- Advertised team
- The site presents Dr. Alande Brezault and Dr. Claude Alain Innocent as board-certified physicians, and Nina Colon as a Master Aesthetician; these credentials were not independently verified.Sources: [7]
- Appointment cancellation
- At least 24 hours’ notice permits cancellation or rescheduling without a charge. Less notice or a no-show incurs a stated $50 fee; changes must be made by phone, not email.Sources: [5]
The business is documented more clearly than the weight-care offering
Everglow describes itself as a local medical spa focused on aesthetics and wellness. Its service list places weight management alongside tattoo removal, microneedling and chemical peels. This is meaningful evidence of the business’s advertised scope, but it does not explain whether weight management involves prescription medication, nonprescription services, counseling or another approach. The placement of those services together should not be read as a clinical description of how weight care is delivered.
The terms identify Everglow Miami as a company registered in Florida and give its address as 9400 NW 12th Ave, Bay 3, Miami, FL 33150. That is the company’s own identification, not an independent corporate-record check. The navigation separately includes “Financing” and “GLP-1.” The contents and accessibility of those linked pages were not established in this review, so their labels cannot supply the missing treatment or financing details.
This distinction is the foundation of the review rather than a technical caveat. Our guide to what public provider documents can prove explains why a service listing supports a narrower conclusion than a complete treatment description. Everglow’s consulted pages establish a business presence and an advertised interest in weight management. They do not establish a specific GLP-1 product, prescribing arrangement or pharmacy relationship. Missing documentation is not proof that those services do not exist.
| Topic | Documented | Still to establish |
|---|---|---|
| Weight management | Listed among aesthetic services | Actual treatment options and clinical process |
| GLP-1 | A navigation link bearing that label | Medication, formulation, route and prescribing arrangements |
| Consultation | Homepage advertises a free consultation | Whether weight-management consultations qualify and what they include |
| Appointments | Phone booking, published hours and cancellation rules | Weight-care visit format and follow-up schedule |
| Financing | A navigation link bearing that label | Lender, rates, eligibility and payment conditions |
Named professionals do not establish a prescribing pathway
The About page presents Dr. Alande Brezault and Dr. Claude Alain Innocent as board-certified physicians. It also identifies Nina Colon as a “Master Aesthetician.” These are provider-published descriptions, not credentials independently verified for this article. The consulted excerpts do not give license numbers, identify the physicians’ board-certification specialties or assign any named person responsibility for weight-management assessment, prescribing or follow-up. An aesthetician’s listed role should not be treated as evidence of a prescribing role.
Everglow says it creates tailored treatment plans addressing individual goals. It also says staff take time to get to know clients, discuss goals, answer questions and address concerns. Those statements describe an intended consultation style. They do not establish which medical history is collected, what examination occurs, whether laboratory tests are required or how decisions about prescription weight treatment are made. The distinction matters because personalization is a broad service claim, not a documented clinical protocol.
For a prospective weight-care patient, the useful next step is to ask who would conduct the assessment and who would remain responsible afterward. The answer should distinguish the consultation professional, any prescribing clinician and any dispensing pharmacy rather than treating the advertised team as interchangeable. The site’s general promises may be compatible with a more detailed process, but that process cannot be reconstructed from staff names and personalization language alone.
Local access is clear; remote care and clinical eligibility are not
Everglow publishes a direct booking number, (305) 200-3734, and asks visitors to call. Its listed hours are Monday through Friday, 10:00 a.m. to 6:00 p.m., with Saturday appointments available by appointment only. Together with the Miami address, these details give readers a practical way to ask about services and availability. They do not establish that every advertised service is offered throughout those hours or that a particular clinician will be available.
The terms restrict use and registration to people age 18 or older. That is an access condition for the services described in the terms, not a documented clinical eligibility rule for weight treatment. The consulted material does not specify weight-management criteria, required testing, contraindication screening or the professional who decides eligibility. Readers should not substitute the website’s adult-use rule for an actual medical assessment or assume that being permitted to register guarantees treatment.
Nor does the documentation confirm telemedicine, service outside Miami, eligible states or languages of care. The consulted text is in English, which does not establish the full range of languages available. Someone seeking remote care should ask explicitly whether an initial visit and subsequent visits can occur remotely, and from which locations. A local address and phone number are useful access facts, but neither establishes a multistate prescribing service.
A free consultation is not a published treatment price
The homepage advertises new-client specials and invites visitors to schedule a free consultation. It does not identify which services qualify or explain the promotion’s detailed conditions. The defensible reading is therefore limited: Everglow advertises a consultation at no charge, but the consulted material does not establish that a weight-management assessment, testing, prescription or medication is included. Anyone booking specifically for weight care should confirm the scope of the advertised consultation before attending.
There is no documented weight-treatment price in the consulted material: no identified medication price, recurring program fee, supply period or itemized inclusion list. The “Financing” navigation label does not establish financing terms, borrower eligibility, interest rates or repayment obligations. Insurance acceptance, insurer reimbursement and the conditions of new-client discounts are also unresolved. Those omissions prevent a meaningful estimate of the first treatment bill or later costs; they do not justify inventing a typical monthly charge.
The appointment policy supplies a narrower payment detail: it says payment for a service is processed after the appointment, while also allowing presentation of a prepaid receipt or order number. That wording recognizes prepaid transactions without explaining which services use them. It does not establish mandatory prepayment, a subscription or a refund entitlement. Before purchasing a package, readers would need written clarification of what is purchased, when charges occur and how unused services are handled.
Appointment rules are specific, but they are not subscription terms
Everglow’s cancellation policy is one of its more concrete documents. It requires at least 24 hours’ notice to cancel or reschedule an appointment without a charge. Appointments canceled with less notice, and appointments missed entirely, incur a stated $50 fee. These are scheduling rules tied to reserved service time. They should not be extended into assumptions about medication renewals, cancellation of a recurring plan, refunds or the treatment of prepaid balances.
The required communication channel is equally important: the policy says cancellation and rebooking requests are not accepted by email. Changes must be made by phone at the scheduled location. Although the privacy-policy contact section publishes help@everglowmiami.com, that email address does not override the appointment policy’s phone-only instruction. A reader who needs to change an appointment should distinguish a general contact route from the route the business says it accepts for that particular action.
The policy also promises courtesy reminders by call, text or email one to two business days before the appointment. It does not say that receiving a reminder is a condition of the cancellation deadline. Separately, no clinical follow-up schedule or medication-support response time is established. As our discussion of clinical follow-up versus renewal notices explains, appointment communications and ongoing medical oversight answer different questions; evidence of one is not evidence of the other.
Privacy documents contain useful disclosures and unresolved tensions
The privacy policy carries an effective date of January 5, 2025. It says Everglow may collect names, email addresses, telephone numbers, mailing addresses and other information provided during consultations or booking, as well as card or other payment details when services are purchased. Declared uses include managing services, communicating about appointments and promotions, processing payments and analyzing trends. These disclosures describe the business’s stated practices; they are not an independent assessment of its security controls.
The policy permits sharing with vendors assisting in payment processing, marketing or website analytics under stated confidentiality agreements. It separately says personal information is not sold or shared with third parties for marketing purposes. Cookies may personalize the site, track usage and deliver preference-based advertising, with browser settings offered as a control. The consulted text does not fully explain how these vendor, advertising and no-marketing-sharing statements fit together, so readers should seek clarification rather than assume either unrestricted sharing or complete isolation.
There is a further documentation tension: the terms say the services are not tailored for HIPAA or FISMA compliance and restrict use where those laws would apply, yet also describe maintaining protected health information from healthcare contacts or visits. The scope of these passages is unclear. The privacy policy offers access and correction rights, but its promotional opt-out instruction retains “[Insert Contact Email].” A separate contact section provides help@everglowmiami.com. These issues justify asking how clinical information and privacy requests are actually handled.
Drug evidence cannot fill in an unidentified service
Clinical research cannot determine what Everglow offers when the treatment itself is unidentified. The consulted business material names no weight-management medicine, brand, formulation, administration route or dispensing pharmacy. It also does not establish whether compounded preparations are used. Consequently, there is no documented product here to match to a particular clinical trial. Published medication results should not be attached to the spa simply because its navigation contains a GLP-1 label.
The broader distinction is explained in why a clinical trial is not a provider performance report. Trials evaluate specified interventions in defined populations under specified conditions. They do not establish this practice’s outcomes, prescribing quality, support process or results for an individual patient. Everglow’s statements about tailored care likewise do not demonstrate weight-loss effectiveness. Provider marketing and testimonials are not independent clinical evidence of safety or efficacy.
If the business later identifies a product, readers can then ask the appropriate evidence questions. Our guide to approved medicines and compounded preparations distinguishes these categories. FDA approval applies to a specific product, not a clinic. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality; nonapproval alone does not establish clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy.
The most useful next evidence would describe the actual care chain
A productive inquiry to Everglow would begin with a simple request: describe the weight-management service currently offered, including whether prescription medicines are involved. If so, the next details are the medicine’s exact identity, formulation and route; who evaluates and prescribes; which pharmacy dispenses; and what follow-up is included. None of those answers should be inferred from the general service list, the advertised physicians or the free-consultation invitation.
The same request should address responsibilities, not just product names. The consulted documentation does not explain required tests, monitoring visits, medication-support channels, response times or urgent-concern procedures. Nor does it describe medication shipping, transportation charges, storage or dispatch and arrival expectations. These are unanswered questions, not evidence that Everglow ships medicines. If injectable GLP-1 delivery is eventually offered, FDA advises not using a product that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy.
Finally, request written financial terms specific to the proposed service rather than relying on the general appointment policy. Useful details include the consultation’s scope, separate testing or medication charges, any recurring billing interval, renewal authorization, cancellation procedure and refund boundaries. Everglow already documents a local access point and specific appointment rules. A service-specific explanation would allow readers to determine whether those established business details connect to a sufficiently clear weight-care arrangement.
Questions & answers
Is Everglow Miami a confirmed GLP-1 provider?
Not on the consulted documentation. Everglow lists weight management and includes a “GLP-1” navigation link, but the reviewed material does not identify a medication, prescribing process or dispensing pharmacy. This review therefore classifies it as related care. That classification describes what can be established from the documentation; it does not prove that a GLP-1 service is unavailable.
Does the advertised free consultation include weight-treatment medication?
The homepage does not say that it does. It advertises new-client specials and a free consultation without identifying eligible services or included components. No medication price or treatment package is documented in the consulted material. Ask whether the consultation applies to weight management and whether assessment, testing, prescribing and any medicine would generate separate charges.
Who would prescribe or supervise weight treatment?
That responsibility is not established. The site names Dr. Alande Brezault and Dr. Claude Alain Innocent as board-certified physicians and Nina Colon as a Master Aesthetician, but does not assign weight-care duties in the consulted excerpts. The advertised credentials were not independently verified. Ask for the name and role of the assessing professional, any prescriber and the clinician responsible for follow-up.
How do I change an Everglow appointment without the stated fee?
The policy requires at least 24 hours’ notice to cancel or reschedule without charge. Less notice or a no-show incurs a stated $50 fee. It specifically rejects email cancellation and rebooking requests, directing clients to call their scheduled location instead. Everglow publishes (305) 200-3734 for booking. These appointment rules do not establish refund or subscription-cancellation terms.
Does Everglow require payment before an appointment?
The appointment policy says service payment is processed after the appointment, but it also permits clients to present a prepaid receipt or order number. It does not explain which purchases are prepaid or provide detailed prepayment conditions. That wording is not evidence of mandatory upfront payment for weight care, nor does it establish what happens to a prepaid balance after cancellation.
What should I clarify before sending detailed health information?
Ask which channel is intended for clinical information and how the practice distinguishes website services from healthcare records. The terms contain both a HIPAA-related service limitation and a statement about maintaining protected health information. The privacy policy also leaves its promotional opt-out email placeholder unfinished, although it separately lists help@everglowmiami.com. These are documentation questions requiring clarification, not a determination that a privacy violation occurred.
Our assessment
Everglow Miami’s public documentation supports a clear, limited conclusion: it is an advertised Miami aesthetic and wellness medical spa with weight management among its services, named professionals, reachable contact channels and specific appointment rules. Those are useful business facts. They do not establish a GLP-1 medication program, a complete clinical pathway or treatment effectiveness. The missing service-specific details and unresolved privacy wording warrant direct clarification, not assumptions of either good or poor clinical care. For readers exploring prescription weight treatment, the decisive next evidence is a written description of the actual offering, responsible clinicians, pharmacy arrangements, follow-up and charges. Until that is available, Everglow is best understood here as related care rather than a verified GLP-1 provider.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Everglow Miami — cancellation policy ↗
- Everglow Miami — terms of service ↗
- Everglow Miami — about ↗
- Everglow Miami — official website ↗
- Everglow Miami — privacy policy ↗